These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37285460)

  • 1. A narrative review on pathogenetic mechanisms of hyperinsulinemic hypoglycemia in Kabuki syndrome.
    Maines E; Maiorana A; Leonardi L; Piccoli G; Soffiati M; Franceschi R
    Endocr Regul; 2023 Jan; 57(1):128-137. PubMed ID: 37285460
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative meta-analysis of Kabuki syndrome with and without hyperinsulinaemic hypoglycaemia.
    Hoermann H; El-Rifai O; Schebek M; Lodefalk M; Brusgaard K; Bachmann N; Bergmann C; Roeper M; Welters A; Salimi Dafsari R; Blankenstein O; Mayatepek E; Christesen H; Meissner T; Kummer S
    Clin Endocrinol (Oxf); 2020 Sep; 93(3):346-354. PubMed ID: 32533869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of KMT2D and KDM6A mutations by exome sequencing in Korean patients with Kabuki syndrome.
    Cheon CK; Sohn YB; Ko JM; Lee YJ; Song JS; Moon JW; Yang BK; Ha IS; Bae EJ; Jin HS; Jeong SY
    J Hum Genet; 2014 Jun; 59(6):321-5. PubMed ID: 24739679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X-Linked Kabuki Syndrome Subtype 2.
    Bögershausen N; Gatinois V; Riehmer V; Kayserili H; Becker J; Thoenes M; Simsek-Kiper PÖ; Barat-Houari M; Elcioglu NH; Wieczorek D; Tinschert S; Sarrabay G; Strom TM; Fabre A; Baynam G; Sanchez E; Nürnberg G; Altunoglu U; Capri Y; Isidor B; Lacombe D; Corsini C; Cormier-Daire V; Sanlaville D; Giuliano F; Le Quan Sang KH; Kayirangwa H; Nürnberg P; Meitinger T; Boduroglu K; Zoll B; Lyonnet S; Tzschach A; Verloes A; Di Donato N; Touitou I; Netzer C; Li Y; Geneviève D; Yigit G; Wollnik B
    Hum Mutat; 2016 Sep; 37(9):847-64. PubMed ID: 27302555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of KMT2D and KDM6A variants by targeted sequencing from patients with Kabuki syndrome and other congenital disorders.
    Yap CS; Jamuar SS; Lai AHM; Tan ES; Ng I; Ting TW; Tan EC
    Gene; 2020 Mar; 731():144360. PubMed ID: 31935506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 9 affected individuals.
    Yap KL; Johnson AEK; Fischer D; Kandikatla P; Deml J; Nelakuditi V; Halbach S; Jeha GS; Burrage LC; Bodamer O; Benavides VC; Lewis AM; Ellard S; Shah P; Cody D; Diaz A; Devarajan A; Truong L; Greeley SAW; De Leó-Crutchlow DD; Edmondson AC; Das S; Thornton P; Waggoner D; Del Gaudio D
    Genet Med; 2019 Jan; 21(1):233-242. PubMed ID: 29907798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kabuki syndrome genes KMT2D and KDM6A: functional analyses demonstrate critical roles in craniofacial, heart and brain development.
    Van Laarhoven PM; Neitzel LR; Quintana AM; Geiger EA; Zackai EH; Clouthier DE; Artinger KB; Ming JE; Shaikh TH
    Hum Mol Genet; 2015 Aug; 24(15):4443-53. PubMed ID: 25972376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis, pathogenic mechanisms, and readthrough therapy on a large cohort of Kabuki syndrome patients.
    Micale L; Augello B; Maffeo C; Selicorni A; Zucchetti F; Fusco C; De Nittis P; Pellico MT; Mandriani B; Fischetto R; Boccone L; Silengo M; Biamino E; Perria C; Sotgiu S; Serra G; Lapi E; Neri M; Ferlini A; Cavaliere ML; Chiurazzi P; Monica MD; Scarano G; Faravelli F; Ferrari P; Mazzanti L; Pilotta A; Patricelli MG; Bedeschi MF; Benedicenti F; Prontera P; Toschi B; Salviati L; Melis D; Di Battista E; Vancini A; Garavelli L; Zelante L; Merla G
    Hum Mutat; 2014 Jul; 35(7):841-50. PubMed ID: 24633898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel
    Salguero MV; Chan K; Greeley SAW; Dyamenahalli U; Waggoner D; Del Gaudio D; Rajiyah T; Lemelman M
    J Endocr Soc; 2022 Apr; 6(4):bvac015. PubMed ID: 35237736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Rare Cause of Hyperinsulinemic Hypoglycemia: Kabuki Syndrome.
    Mısırlıgil M; Yıldız Y; Akın O; Odabaşı Güneş S; Arslan M; Ünay B
    J Clin Res Pediatr Endocrinol; 2021 Nov; 13(4):452-455. PubMed ID: 32830475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent Hypoglycemia and Hyperinsulinism in a Patient With
    Nunez Stosic M; Gomez P
    JCEM Case Rep; 2023 Mar; 1(2):luad032. PubMed ID: 37908464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a KDM6A somatic mutation responsible for Kabuki syndrome by excluding a conflicting KMT2D germline variant through episignature analysis.
    Kawai T; Iwasaki Y; Ogata-Kawata H; Kamura H; Nakamura K; Hata K; Takano T; Nakabayashi K
    Eur J Med Genet; 2023 Aug; 66(8):104806. PubMed ID: 37379880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Molecular Characterization of Hyperinsulinism in Kabuki Syndrome.
    Rosenfeld E; Mitteer LM; Boodhansingh K; Sanders VR; McKnight H; De Leon DD
    J Endocr Soc; 2024 May; 8(7):bvae101. PubMed ID: 38859884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling molecular pathways shared by Kabuki and Kabuki-like syndromes.
    Lintas C; Persico AM
    Clin Genet; 2018 Oct; 94(3-4):283-295. PubMed ID: 28139835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome.
    Lindsley AW; Saal HM; Burrow TA; Hopkin RJ; Shchelochkov O; Khandelwal P; Xie C; Bleesing J; Filipovich L; Risma K; Assa'ad AH; Roehrs PA; Bernstein JA
    J Allergy Clin Immunol; 2016 Jan; 137(1):179-187.e10. PubMed ID: 26194542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of genetic and phenotypic heterogeneity in 37 Turkish patients with Kabuki and Kabuki-like phenotype.
    Usluer E; Sayın GY; Güneş N; Kasap B; Tüysüz B
    Am J Med Genet A; 2022 Oct; 188(10):2976-2987. PubMed ID: 36097644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital hyperinsulinism and novel KDM6A duplications -resolving pathogenicity with genome and epigenetic analyses.
    Männistö JME; Hopkins JJ; Hewat TI; Nasser F; Burrage J; Dastamani A; Mirante A; Murphy N; Rzasa J; Kerkhof J; Relator R; Johnson MB; Laver TW; Weymouth L; Houghton JAL; Wakeling MN; Sadikovic B; Dempster EL; Flanagan SE
    J Clin Endocrinol Metab; 2024 Jul; ():. PubMed ID: 39078990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kabuki syndrome: novel pathogenic variants, new phenotypes and review of literature.
    Shangguan H; Su C; Ouyang Q; Cao B; Wang J; Gong C; Chen R
    Orphanet J Rare Dis; 2019 Nov; 14(1):255. PubMed ID: 31727177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel KDM6A splice-site mutation in kabuki syndrome with congenital hydrocephalus: a case report.
    Guo Z; Liu F; Li HJ
    BMC Med Genet; 2018 Dec; 19(1):206. PubMed ID: 30509212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic analysis in 14 Czech Kabuki syndrome patients is confirming the utility of phenotypic scoring.
    Paděrová J; Holubová A; Simandlová M; Puchmajerová A; Vlčková M; Malíková M; Pourová R; Vejvalková S; Havlovicová M; Šenkeříková M; Ptáková N; Drábová J; Geryk J; Maver A; Křepelová A; Macek M
    Clin Genet; 2016 Sep; 90(3):230-7. PubMed ID: 26841933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.